Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02192 MEDLIVE
RT Nominal unchange14.180 0.000 (0.000%)
Ranking Overview
Buy
Ranking based on 3 research report(s)
Average Ranking 2.33
0
2
1
0
0
Previous Financial Performance
Financial Year 12/2024 EPS 43.23 RMB (cts)
Net Profit 315.15 RMB (MIL) DPS 25.71 RMB (cts)
Consolidation Estimation
Financial Year Profit / (Loss)
(RMB (MIL))
EPS/
((LPS)(RMB (cts))
DPS
(RMB (cts))
Net Asset Value per Share
(RMB)
Highest
(RMB (MIL))
Lowest
(RMB (MIL))
2025304.0043.0025.00--342.00300.00
2026328.0047.0025.00--402.00299.00
2027370.0053.0024.00--465.00291.00
Profit Estimation
Profit Estimation Profit / (Loss)
(RMB (MIL))
EPS*/
(LPS) (RMB (cts))
DPS *
(RMB (cts))
Broker Ranking Target Price*
(HKD)
Update Date
2025342.0047.00--CITIC SECBuy19.00 28/03/2025
2025304.0043.00--HAITONGOutPerform15.00 11/04/2025
2025300.0041.0025.00HSBCHold13.50 25/03/2025
 
2026402.0055.00--CITIC SEC----28/03/2025
2026328.0047.00--HAITONG----11/04/2025
2026299.0041.0025.00HSBC----25/03/2025
 
2027465.0063.00--CITIC SEC----28/03/2025
2027370.0053.00--HAITONG----11/04/2025
2027291.0039.0024.00HSBC----25/03/2025
Remarks:  Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa.
  *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue
  Real time quote last updated: 23/07/2025 07:50
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service